Filter posts

PTO Genetic Testing Study: What's Patents Got to Do with It

The USPTO held a hearing on February 16 to collect testimony from interested parties to …

Biotech IP Challenges Around the World: BIO’s Special 301 Submission

BIO recently submitted its Special 301 Submission highlighting intellectual property (IP) challenges around the world.  …

AUTM Website Helps Commercialize University Technologies

By Robin L. Rasor, CLP, RTTP, AUTM President As president of the Association of University …

Patent Awards for Humanitarian Ventures

The USPTO recently announced the Patents for Humanity Challenge which awards patent owners and licensees …

Is the Polio Vaccine an Anti-Patent Success Story?

By Hans Sauer, Deputy General Counsel for Intellectual Property, Biotechnology Industry Organization Question from a Reader: …

The Real Reason Why Salk Refused to Patent the Polio Vaccine

Editor’s Note: Despite the progress in polio and other diseases made possible by vaccines, today …

Brazilian Innovation: A Patent Success

The story of Acheflan highlights the role of patents in homegrown innovation in developing countries.  …

NIH Licensing Efforts Target Start-Ups

The National Institutes of Health (NIH) has developed a new short-term licensing arrangement they hope …

Exclusive Licenses Do Not Discourage Follow On Research

A recent study presented at the Patent Statistics for Decision Makers Conference organized at the …

BIO's Prometheus v. Mayo Amicus Brief Filed

BIO filed an amicus brief in the Prometheus v. Mayo Clinic case.  In this case …